Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor
- 1 August 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 58 (2), 549-558
- https://doi.org/10.1046/j.1523-1755.2000.t01-1-00201.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Identification of an Essential Signaling Cascade for Mitogen-activated Protein Kinase Activation by Angiotensin II in Cultured Rat Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1996
- Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptorsNature, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996
- Thromboxane A 2 and Vascular Smooth Muscle Cell ProliferationHypertension, 1995
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- Regulation of cell proliferation and growth by angiotensin IIProgress in Growth Factor Research, 1994
- Atrial natriuretic peptide blunts the cellular effects of cyclosporine in smooth muscle.Hypertension, 1993
- Growth factor signaling by receptor tyrosine kinasesNeuron, 1992
- Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertensionCardiovascular Drugs and Therapy, 1990
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989